United Therapeutics CEO trusts sell 1,614 shares
The pre-arranged plan adopted November 7, 2025, continues until the earlier of exercise of 1,734,410 stock options or December 31, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
United Therapeutics (UTHR) common shares held in family trusts where Chairperson & CEO Martine A. Rothblatt shares investment power were sold: 1,614 shares on November 9, 2026. Reported weighted-average prices were $583.8007 for 494 shares, $584.7001 for 840 shares, and $585.6258 for 280 shares; each price reflects multiple trades. The sales were pursuant to a pre-arranged 10b5-1 trading plan adopted November 7, 2025. The report also lists 40,513 common shares held directly and 166 held by her spouse.
Insider Trade Summary 10b5-1
Net Seller: 1,614 shares
Net Sell
3 txns
Insider
ROTHBLATT MARTINE A
Role
Chairperson & CEO
Sold
1,614 shs ($944K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1, F2, F3 | 494 | $583.8007 | $288K |
| Sale | Common Stock F1, F4, F3 | 840 | $584.7001 | $491K |
| Sale | Common Stock F1, F5, F3 | 280 | $585.6258 | $164K |
| Holding | Common Stock | -- | -- | -- |
| Holding | Common Stock | -- | -- | -- |
| Holding | Common Stock F6 | -- | -- | -- |
| Holding | Common Stock F7 | -- | -- | -- |
| Holding | Common Stock F8 | -- | -- | -- |
Holdings After Transaction:
Common Stock — 628,049 shares (Indirect, by Trust);
Common Stock — 40,513 shares (Direct);
Common Stock — 166 shares (Indirect, by Spouse)
Footnotes (8)
- F1. This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026.
- F2. This transaction was executed in multiple trades at prices ranging from $583.21 to $584.14. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3. Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
- F4. This transaction was executed in multiple trades at prices ranging from $584.24 to $585.19. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5. This transaction was executed in multiple trades at prices ranging from $585.39 to $586.30. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6. Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- F7. Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
- F8. Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
Key Figures
Common shares sold: 494 shares
Weighted-average sale price: $583.8007 per share
Common shares sold: 840 shares
+5 more
8 metrics
Common shares sold
494 shares
November 9, 2026
Weighted-average sale price
$583.8007 per share
For the 494 shares sold on November 9, 2026
Common shares sold
840 shares
November 9, 2026
Weighted-average sale price
$584.7001 per share
For the 840 shares sold on November 9, 2026
Common shares sold
280 shares
November 9, 2026
Weighted-average sale price
$585.6258 per share
For the 280 shares sold on November 9, 2026
Common shares held directly
40,513 shares
Reported holding as of November 9, 2026
Common shares held by spouse
166 shares
Reported holding as of November 9, 2026
Key Terms
pre-arranged 10b5-1 trading plan, weighted average price, investment power
3 terms
pre-arranged 10b5-1 trading plan regulatory
"sale was pursuant to a pre-arranged 10b5-1 trading plan"
weighted average price financial
"the price reported above reflects the weighted average price"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
investment power regulatory
"family trusts as to which the Reporting Person shares investment power"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
When does the UTHR trading plan end?
The pre-arranged 10b5-1 trading plan continues until the earlier of exercise of 1,734,410 stock options or December 31, 2026. The plan was adopted November 7, 2025, and the options expire March 15, 2027.
AI-generated analysis. How Rhea-AI works. Not financial advice.
